Gavin Robertson, professor of pharmacology, pathology, dermatology, and surgery; director of the Penn State Melanoma and Skin Cancer Center and member of Penn State Cancer Institute, works with associates in the Melanoma Center. The first of a new class of medication that delivers a combination of drugs by nanoparticle may keep melanoma from becoming resistant...